BSE filing, NSE: GRAPHITE. Summary written from the filing by ALFA Finder's alert engine.
Graphite India Ltd: key numbers
- Share price
- ₹733.65
- Market cap
- ₹14,334 Cr
- Revenue (annual)
- ₹2,852 Cr
- Net profit (annual)
- ₹175.3 Cr
- P/E (TTM)
- 67.6×Sector 52.0×
- Promoter holding
- 65.34%+0.00% QoQ
- FII holding
- 8.11%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Graphite India Ltd
All →Graphite India Board Meeting Date
Graphite India will hold a board meeting on 3 November 2026 to approve September 2026 quarter results. The trading window reopens on 6 November 2026.
Graphite India Acquisition Worth ₹58.71 Cr
Graphite India invested Rs. 58.71 Crore in GIPL's rights issue, raising its stake to 52.68%. This deepens its foothold in supercapacitor and battery materials R&D.
- Value
- ₹58.71 Cr
Graphite India Other Announcement
Graphite India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory compliance.
Graphite India Legal & Regulatory
Graphite India announced a preliminary affirmative determination in a U.S. antidumping duty investigation, with a 9.88% cash deposit rate. Financial impact is currently un-ascertainable.
Graphite India Earnings Call Transcript: Key Takeaways
Graphite India delivered robust Q1 FY2027 performance with consolidated revenue growing 26.6% y-o-y. Strategy focuses on electrode capacity expansion and synthetic graphite anode materials (SGAM).
Graphite India Other Announcement
Graphite India received an ESG score of 66 (Performer) from Niche99. The disclosure is a routine Reg 30 compliance intimation with no financial impact.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.